Antiviral Drug Discovery To Address the COVID-19 Pandemic
ABSTRACT The magnitude of the morbidity and mortality inflicted upon the global population in less than 1 year has driven the inescapable conclusion that the discovery and development of effective antiviral drugs for COVID-19 are urgent and should be prioritized. The antiviral drug discovery program...
Guardado en:
Autor principal: | Douglas D. Richman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43566cc0f43b48138638aba667090e53 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Maria L. Agostini, et al.
Publicado: (2018) -
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
por: María E. Cárdaba-García, et al.
Publicado: (2021) -
In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2
por: Minwoo Kim, et al.
Publicado: (2021) -
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
por: Su-Jin Park, et al.
Publicado: (2020) -
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Shin-ichiro Hattori, et al.
Publicado: (2020)